HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

The Personal Care Products Council hosts an event at the Republican National Convention. More news in brief.

You may also be interested in...



Council-Approved Cosmetics Safety Bill Launches

Rep. Leonard Lance, R-N.J., introduces the Cosmetic Safety Amendments Act of 2012, with “the full support” of the Personal Care Products Council. Bill would not require manufacturers to substantiate product safety prior to market or pay user fees, but it does include registration, ingredient disclosure and adverse-event reporting requirements and proposes a significant increase in FDA’s oversight role.

Dove Line May Capture Men Who've Dropped The Axe On The Mating Game

Unilever is extending its Dove personal-care brand with the line's first offerings designed specifically for men - presumably those who have outgrown its prurient Axe grooming brand

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018262

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel